Cilostazol activates AMP-activated protein kinase and restores endothelial function in diabetes.
about
Nitric oxide-induced activation of the AMP-activated protein kinase α2 subunit attenuates IκB kinase activity and inflammatory responses in endothelial cellsBridging Type 2 Diabetes and Alzheimer's Disease: Assembling the Puzzle Pieces in the Quest for the Molecules With Therapeutic and Preventive PotentialMolecular insights and therapeutic targets for diabetic endothelial dysfunction.Vascular protection by tetrahydrobiopterin: progress and therapeutic prospectsWhen hypothermia meets hypotension and hyperglycemia: the diverse effects of adenosine 5'-monophosphate on cerebral ischemia in rats.AMP-activated protein kinase pathway: a potential therapeutic target in cardiometabolic disease.Adenosine Monophosphate-Activated Protein Kinase (AMPK) as a New Target for Antidiabetic Drugs: A Review on Metabolic, Pharmacological and Chemical Considerations.Clinical Implication of Plasma Hydrogen Sulfide Levels in Japanese Patients with Type 2 Diabetes.AMP-activated protein kinase: a stress-responsive kinase with implications for cardiovascular disease.AMP-activated protein kinase mediates the effects of lipoprotein-associated phospholipase A2 on endothelial dysfunction in atherosclerosis.AMP-activated protein kinase activators in diabetic ulcers: from animal studies to Phase II drugs under investigation.Pharmacological treatment and therapeutic perspectives of metabolic syndrome.Exercise performance and peripheral vascular insufficiency improve with AMPK activation in high-fat diet-fed mice.Macro- and microvascular endothelial dysfunction in diabetes.Tissue-resident ecto-5' nucleotidase (CD73) regulates leukocyte trafficking in the ischemic brain.Role of Cilostazol Therapy in Hemodialysis Patients with Asymptomatic Peripheral Arterial Disease: A Retrospective Cohort Study.AMPK activity is down-regulated in endothelial cells of GHS-R(-/-) mice.Cilostazol Suppresses Aβ-induced Neurotoxicity in SH-SY5Y Cells through Inhibition of Oxidative Stress and MAPK Signaling Pathway.Toxicity of a novel therapeutic agent targeting mitochondrial complex I.Effects of cilostazol and renin-angiotensin system (RAS) blockers on the renal disease progression of Korean patients: a retrospective cohort study.How AMPK and PKA Interplay to Regulate Mitochondrial Function and Survival in Models of Ischemia and Diabetes.Cilostazol exerts antiplatelet and anti-inflammatory effects through AMPK activation and NF-kB inhibition on hypercholesterolemic rats.
P2860
Q27335298-7137448B-EC4C-4CCF-94CF-5524771AF8ECQ29994589-465C90D2-5598-419D-97D2-D17296AE33C5Q34022332-EB7AF4FA-7657-4EAF-8296-2EFBC7621FAAQ37087728-78511B9F-9418-4C1D-A12F-650BE61B9CDDQ37304516-483846DC-AD38-4230-8713-BFBFA8B71F43Q37411713-8AF42549-505B-45D9-963A-9235BA5724DDQ37531997-8BF84042-E539-49A8-8814-B278FFE45EAFQ37647418-D2354ECD-09F7-40C3-91B6-5E4A06E2486CQ37671250-760C4DD4-933D-49F4-A83D-2491843B208DQ37734982-D63900F8-6A5C-4A2A-89A1-7F6D687C7F98Q38214392-1169952F-23A1-415A-9976-2457D85F21FAQ38262435-16004D5A-61E0-4732-B72D-041B074A8894Q38799483-53AD6EEF-369D-4C00-9548-9ACA1B7ED82FQ39065434-A920C6D2-657B-4BE3-93B4-CA8E590E3D3BQ40418538-F45C1D89-D415-4EE1-BB68-2BB549A04626Q42385835-408C0D5B-191F-4AD6-9C13-7F7D62DAE12DQ42580149-2D8F4F27-B74D-481B-837C-778DF0C8BCFFQ46271236-48679CC3-9537-48B8-9787-8634C47E4D77Q47684621-8CB3B8FF-6002-49FF-BBF5-E3B6AE7CA824Q47761508-0FA2A740-A133-4D51-8E94-E5B0DB3E50BBQ48042214-D1285DF7-9220-4F45-BF85-9699A2EF898AQ54210012-6EA29FF3-F138-423A-9E83-3545FF01CA0A
P2860
Cilostazol activates AMP-activated protein kinase and restores endothelial function in diabetes.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Cilostazol activates AMP-activ ...... othelial function in diabetes.
@en
Cilostazol activates AMP-activ ...... othelial function in diabetes.
@nl
type
label
Cilostazol activates AMP-activ ...... othelial function in diabetes.
@en
Cilostazol activates AMP-activ ...... othelial function in diabetes.
@nl
prefLabel
Cilostazol activates AMP-activ ...... othelial function in diabetes.
@en
Cilostazol activates AMP-activ ...... othelial function in diabetes.
@nl
P2093
P2860
P356
P1476
Cilostazol activates AMP-activ ...... othelial function in diabetes.
@en
P2093
Kohsuke Uchida
Kunihiro Suzuki
Nobuo Nakanishi
Yoshiyuki Hattori
P2860
P304
P356
10.1038/AJH.2008.6
P577
2008-02-07T00:00:00Z